TABLE 2

Adverse event incidence, frequency, and severity for each study group

AE measureFlexyn2a (n = 12)Flexyn2a + alum (n = 12)Placebo (n = 6)a
Overall AE incidence, no. (%)9 (75)10 (83)6 (100)
Frequency of AEs373724
Severity, no (%)
    Mild31 (84)29 (78)22 (92)
        Not related19 (51)14 (38)18 (75)
        Related12 (33)15 (40)4 (17)
    Moderate3 (8)7 (19)1 (4)
        Not related3 (8)5 (14)1 (4)
        Related2 (5)
    Severe3 (8)1 (3)1 (4)
        Not related3 (8)1 (3)1 (4)
        Related
  • a One subject received only the first injection.